3D Cell Culture: From Academia To Big Pharma

What a difference a decade makes. Today, 3D cell culture isn't just the stuff of obscure posters or presentations; entire conferences examine the promise of 3D. And big pharma is getting involved: The 3D Cell Culture 2020 conference in Germany, which was postponed in response to the coronavirus pandemic, was slated to include pharmaceutical voices on its planning committee and in its lectures.

While literature had long praised the promise of 3D, the industry uptake didn't accelerate until it became operationally feasible to produce 3D work at scale. Commercial tools and technologies that make 3D more accessible and less labor-intensive have helped make that happen.